Research > ETFs > ETF / ETP Commentary > 

ETFs for the Next Leg of Earnings Expansion

The Q2 earnings season is still in its early days, but it’s already handing us a reality check: growth is broadening out. These conditions are putting one tried-and-tested segment of smart beta ETFs, the equal-weighted strategies, into sharp focus. And investors are taking notice. Key Takeaways:  Earnings growth is broadening, with S&P 500 on track for a strong 24% YoY earning expansion in Q2.   The “S&P 493” catch-up is gaining momentum with analysts expecting these stocks to outpace the Mag 7 in Q2.   Equal-weighted ETFs are standing out as a way to mitigate tech/AI concentration risk and capture gains across broader market leaders. Broadening Market LeadershipAccording to FactSet data, not only is earnings growth on track for 24% year over year in Q2, but the underlying fundamental strength is broadening out across most corners of the market. Ten sectors are on track for positive earnings growth (healthcare being the exception), and all 11 sectors are expected to show revenue growth. Consider, too, that midway through July, about two-thirds of the S&P 500 are showing serious momentum, with stocks trading above their respective 50-day moving averages. (Data point courtesy of Cameron Dawson, CIO at NewEdge Wealth).Equal Weight vs Market-Cap WeightA look at the Invesco S&P 500 Equal Weight ETF (RSP) vs the SPDR Portfolio S&P 500 ETF (SPYM) shows outperformance in the equal-weighted S&P 500 basket, confirming that broadening story as well.“In aggregate, the Magnificent 7 companies have reported higher (year-over-year) earnings growth than the other 493 companies in the S&P 500 over the past several quarters,” John Butters at FactSet said in his latest note. “Is this trend expected to continue in Q2 2026? The answer is yes.” That said, the blended earnings Q2 growth rate (expected) for the other 493 companies in the S&P 500 is 22.8%, which if it materializes, would be the highest year-over-year growth rate these companies have seen since late 2021, he noted. “In fact, four of the five top contributors to earnings growth for the S&P 500 for Q2 2026 are not Magnificent 7 companies,” he said. “It is interesting to note that analysts expect higher earnings growth for the other 493 companies in the 2nd half of 2026.”150+ Equal Weighted ETFs To ExploreRSP has picked up $1.5 billion in net new money in July alone, bringing its year-to-date asset haul to more than $11 billion. The fund is currently among the 15 most popular ETFs of the year. RSP is a sort of poster child for the equal-weighted ETF category, but there are more than 150 equal weighted ETFs with about $100 billion in assets spread across them. For example, the Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW B+) has delivered double digit gains this year, and is finding traction with investors worried about tech and AI-related concentration risk. At a sector level, the ALPS Equal Sector Weight ETF (EQL B) equal-weights each sector in the portfolio at just under 10% allocation each. That’s a lot less tech exposure vs. the 37% seen in the S&P 500, and a lot more materials, utilities, energy and real estate exposure. Or the Invesco S&P 500 Equal Weight Technology ETF (RSPT) equal-weights the tech sector alone in a strategy that has more than $5 billion in total assets. The Invesco QQQ Equal Weight ETF (QEW) is another example of an equal weighted approach to a popular benchmark: the Nasdaq 100 index benchmarking the Invesco QQQ ETF (QQQ). This past week, QEW’s performance just edged higher above QQQ’s year-to-date results. In QEW, tech is about 47% of the sector exposure vs. nearly 69% in QQQ. While the top four holdings in QEW represent about 5% of the portfolio, in the Qs the top four stocks snag 25% of the mix, with Nvidia leading at 8%. Concentration risk is real.Smart Beta Solving Investor NeedsEqual-weighted ETFs are often overlooked in bull markets where market leadership is narrow, much like the one we’ve seen in the past couple of years. Their evenly distributed stock weights typically lag when a handful of stocks leads the pack. But in 2026, the earnings gap between the Mag 7 and the 493 is narrowing, and expectations are pointing to a continuation of momentum in some of the market’s most overlooked names. In this environment, a smart beta approach offers a simple, elegant solution to concentration risk while positioning portfolios to capture a broadening story. For a list of equal weighted ETFs, check our ETF Screener. For more news and information, visit the Smart Beta Content Hub VettaFi LLC (“VettaFi”) is the index provider for EQL, for which it receives an index licensing fee. However, EQL is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of EQL.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.